Praxis Precision Medicines, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Praxis Precision Medicines, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
  • Praxis Precision Medicines, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$32.7M, a 4.77% increase year-over-year.
  • Praxis Precision Medicines, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$124M, a 21.1% increase year-over-year.
  • Praxis Precision Medicines, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$123M, a 42.4% increase from 2022.
  • Praxis Precision Medicines, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$214M, a 28.1% decline from 2021.
  • Praxis Precision Medicines, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$167M, a 170% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$123M +$90.8M +42.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$214M -$47M -28.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$167M -$105M -170% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-07
2020 -$61.8M -$26.3M -74.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 -$35.5M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.